Literature DB >> 2092309

Quality of life as a function of HIV classification.

D Ragsdale1, J R Morrow.   

Abstract

The purpose of this research was to identify variables related to life quality for persons with Human Immunodeficiency Virus Infection and to ascertain if life quality differs according to the classifications of a positive serologic test for HIV antibodies (HIV+), AIDS-related complex (ARC), and Acquired Immunodeficiency Syndrome (AIDS). A convenience sampling technique was used to obtain subjects from AIDS support groups and affiliated agencies in a major southwest urban area. Ninety-five HIV-infected subjects completed a demographic data sheet, the Sickness Impact Profile (SIP), and the Symptom Distress Scale (SDS). The majority of subjects (59%) listed AIDS as their category of diagnosis, 25% were HIV+ only and 16% identified ARC as their disease classification. Subjects had SIP and SDS scores which indicated HIV-infection significantly affected their quality of life. Multivariate results indicated that quality of life indicators varied as a function of HIV classification. HIV-infection had the greatest disruption in psychosocial aspects of life. The impact of HIV-infection (both physical and psychosocial) was greatest in subjects with ARC and least among subjects who were HIV+ only.

Entities:  

Mesh:

Year:  1990        PMID: 2092309

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  19 in total

Review 1.  Nursing research into quality of life.

Authors:  G V Padilla; M M Grant; B Ferrell
Journal:  Qual Life Res       Date:  1992-10       Impact factor: 4.147

Review 2.  A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials.

Authors:  Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36.

Authors:  E A Schlenk; J A Erlen; J Dunbar-Jacob; J McDowell; S Engberg; S M Sereika; J M Rohay; M J Bernier
Journal:  Qual Life Res       Date:  1998-01       Impact factor: 4.147

Review 4.  Health-related quality-of-life evaluation in HIV-infected patients. A review of the literature.

Authors:  J B de Boer; F S van Dam; M A Sprangers
Journal:  Pharmacoeconomics       Date:  1995-10       Impact factor: 4.981

5.  The impact of denial on health-related quality of life in patients with HIV.

Authors:  Charles Kamen; Stacy Taniguchi; Ami Student; Eliza Kienitz; Katherine Giles; Christine Khan; Susanne Lee; Cheryl Gore-Felton; Cheryl Koopman
Journal:  Qual Life Res       Date:  2011-10-26       Impact factor: 4.147

6.  Functional impairment trajectories among persons with HIV disease: a hierarchical linear models approach.

Authors:  S Crystal; U Sambamoorthi
Journal:  Health Serv Res       Date:  1996-10       Impact factor: 3.402

7.  Describing the health-related quality of life impact of HIV infection: findings from a study using the HIV Overview of Problems--Evaluation System (HOPES).

Authors:  P A Ganz; C A Coscarelli Schag; B Kahn; L Petersen; K Hirji
Journal:  Qual Life Res       Date:  1993-04       Impact factor: 4.147

8.  Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument.

Authors:  D F Cella; N L McCain; A H Peterman; F Mo; D Wolen
Journal:  Qual Life Res       Date:  1996-08       Impact factor: 4.147

9.  Effects of liver disease on the well-being of persons living with HIV.

Authors:  Wendy A Henderson; Jane M Fall-Dickson; Elizabeth A Schlenk; Kevin H Kim; Judith T Matthews; Judith A Erlen
Journal:  J Assoc Nurses AIDS Care       Date:  2008 Sep-Oct       Impact factor: 1.354

10.  Predictors of self-reported health-related quality of life in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Vibeke Strand; Hong Fang; Jawali Jaranilla; Michelle Petri
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.